Hutchmed (China)
HCM
Enerpac Tool
EPAC
Ermenegildo Zegna NV
ZGN
Lantheus
LNTH
eBay
EBAY
US Stock MarketDetailed Quotes
ACIU AC Immune
- 2.570
- -0.030-1.15%
Close Feb 25 16:00 ET
- 2.570
- 0.0000.00%
Post 20:01 ET
254.28MMarket Cap-5.74P/E (TTM)
2.689High2.530Low131.30KVolume2.600Open2.600Pre Close337.60KTurnover0.33%Turnover RatioLossP/E (Static)98.94MShares4.97852wk High1.74P/B102.35MFloat Cap2.25052wk Low--Dividend TTM39.83MShs Float19.970Historical High--Div YieldTTM6.12%Amplitude1.680Historical Low2.571Avg Price1Lot Size
About AC Immune Company
AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.
Company Profile
SymbolACIU
Company NameAC Immune
Listing DateSep 23, 2016
Issue Price11.00
Founded2003
CEODr. Andrea Pfeifer, PhD
MarketNASDAQ
Employees161
Fiscal Year Ends12-31
AddressEPFL Innovation Park,Building B
CityLausanne
ProvinceVaud
CountrySwitzerland
Zip Code1015
Phone41-21-345-91-21
Websitehttp://www.acimmune.com
Company Executives
- Name
- Position
- Salary
- Dr. Andrea Pfeifer, PhD
- Chief Executive Officer and Director
- --
- Howard Donovan
- Chief Human Resources Officer
- --
- Piergiorgio Donati
- Chief Technical Operations Officer
- --
- Christopher Roberts
- Chief Financial Officer
- --
- Dr. Nuno Mendonça, M.D.
- Chief Medical Officer
- --
- Jean-Fabien Monin
- Chief Administrative Officer
- --
- Dr. Madiha Derouazi, PhD
- Chief Scientific Officer
- --
- Mark Danton
- Senior Vice President Information Systems and Artificial Intelligence
- --
- Dr. Gary Waanders, PhD
- Senior Vice President, Investor Relations and Corporate Communications
- --
- Dr. Olivier Sol, M.D.
- Vice President and Head of Clinical Development
- --
- Dr. Bojana Portmann, PhD
- Vice President, IP and Business Development
- --
- Dr. Julien Rongere, PhD
- Senior Vice President, Regulatory Affairs and Quality Assurance
- --
- Dr. Douglas E. WilliaPhD
- Chairman of the Board
- --
- Professor Dr. Monika Butler, PhD
- Vice Chairman of the Board and Director
- --
- Monica Shaw
- Independent Director
- --
- Dr. Roy Twyman, M.D.
- Independent Director
- --
- Dr. Werner Lanthaler, PhD
- Independent Director
- --
- Professor Carl June, M.D.
- Independent Director
- --
- Dr. Julian Gray, PhD
- Clinical Advisor
- --
- Dr. Marie Kosco-Vilbois, PhD
- Scientific Advisor
- --
- Alexandre Caratsch
- General Counsel
- --